Monoclonal antibody LYM-1-gelonin conjugate
Alternative Names: LYM-1-gelonin immunoconjugateLatest Information Update: 19 Sep 2011
Price :
$50 *
At a glance
- Originator Albert Einstein College of Medicine; Nonindustrial source; University of Southern California; University of Texas M. D. Anderson Cancer Center
- Developer Albert Einstein College of Medicine; University of Southern California; University of Texas M. D. Anderson Cancer Center
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action B cell inhibitors; Protein synthesis inhibitors; RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Lymphoma
Most Recent Events
- 19 Sep 2011 Discontinued - Preclinical for Lymphoma in USA (unspecified route)
- 02 Jul 1998 No Development Reported - Preclinical for Lymphoma in USA (unspecified route)
- 30 May 1996 Preclinical development for Lymphoma in USA (unspecified route)